A new study raises concerns about a widely used shortcut in approving rectal cancer drugs, showing that the absence of detectable tumors after treatment—known as pathologic complete response (pCR)—does not reliably predict longer survival. The FDA-approved metric could be fast-tracking new rectal cancer drugs without evidence they help patients live longer. 

A new study sponsored by Mirvie, which is the first to evaluate U.S. Preventive Services Task Force (USPSTF) guidelines for preeclampsia risk and aspirin prescription in a single, nationally representative, prospective population, found while high-risk factors had sufficient value in estimating risk, there’s limited value for the moderate risk category - leading to nonspecific recommendations for aspirin use, a recognized prevention tool.

About The Study: In line with prior research, the results of this study indicate that the public has certain reservations about the integration of artificial intelligence (AI) in health care. While the present effect sizes are relatively small, in particular regarding AI use for administrative purposes, they may be highly relevant as trust in health care practitioners is closely linked to subjective treatment outcomes. 

Several local factors — including the minimum temperature reached in autumn, the water level in lakes and ponds in winter, and the presence of mute swans (Cygnus olor) — could be key for predicting the potential of an outbreak of highly pathogenic avian flu (HPAI) occurring in Europe. The findings, published in Scientific Reports...

Researchers from Drexel University’s A.J. Drexel Autism Institute examined hospitalizations for mental health conditions in autistic adults to understand what features are associated with an increased risk for readmission to the hospital within a month of the initial discharge.

At ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) from July 27-31 in Chicago, laboratory medicine experts will communicate the awe-inspiring power of this field to advance healthcare and transform lives around the globe. Presented this year in partnership with the Canadian Society of Clinical Chemists (CSCC), the meeting will delve into a variety of timely topics, including urgent problems related to clinical AI integration, fake medical news, and the pervasiveness of plastics, as well as tapping into the promise of genomics and microbiome medicine for personalized healthcare.

A University of Cincinnati College of Medicine researcher has been awarded a $2.6 million federal grant to study a potentially deadly form of heart disease that affects people with diabetes called diabetic cardiomyopathy.